Does aspirin increase the risk of age-related macular degeneration?

Research output: Contribution to journalLetterOther

2 Citations (Scopus)

Abstract

This commentary on the review by Christen and Chew discusses the controversy surrounding aspirin use and its association with age-related macular degeneration (AMD). We address the strength of evidence between low-dose aspirin use and AMD and also discuss the risks and benefits of aspirin use in primary versus secondary prevention of cardiovascular diseases in these cases. We also highlight an ongoing randomized controlled trial in this area
Original languageEnglish
Pages (from-to)691 - 693
Number of pages3
JournalExpert Opinion on Drug Safety
Volume13
Issue number6
DOIs
Publication statusPublished - 2014

Cite this

@article{f18dadf850154938b093c0b0e51c83cf,
title = "Does aspirin increase the risk of age-related macular degeneration?",
abstract = "This commentary on the review by Christen and Chew discusses the controversy surrounding aspirin use and its association with age-related macular degeneration (AMD). We address the strength of evidence between low-dose aspirin use and AMD and also discuss the risks and benefits of aspirin use in primary versus secondary prevention of cardiovascular diseases in these cases. We also highlight an ongoing randomized controlled trial in this area",
author = "Chong, {Elaine W} and Guymer, {Robyn Heather} and Liubov Robman",
year = "2014",
doi = "10.1517/14740338.2014.914169",
language = "English",
volume = "13",
pages = "691 -- 693",
journal = "Expert Opinion on Drug Safety",
issn = "1474-0338",
publisher = "Taylor & Francis",
number = "6",

}

Does aspirin increase the risk of age-related macular degeneration? / Chong, Elaine W; Guymer, Robyn Heather; Robman, Liubov.

In: Expert Opinion on Drug Safety, Vol. 13, No. 6, 2014, p. 691 - 693.

Research output: Contribution to journalLetterOther

TY - JOUR

T1 - Does aspirin increase the risk of age-related macular degeneration?

AU - Chong, Elaine W

AU - Guymer, Robyn Heather

AU - Robman, Liubov

PY - 2014

Y1 - 2014

N2 - This commentary on the review by Christen and Chew discusses the controversy surrounding aspirin use and its association with age-related macular degeneration (AMD). We address the strength of evidence between low-dose aspirin use and AMD and also discuss the risks and benefits of aspirin use in primary versus secondary prevention of cardiovascular diseases in these cases. We also highlight an ongoing randomized controlled trial in this area

AB - This commentary on the review by Christen and Chew discusses the controversy surrounding aspirin use and its association with age-related macular degeneration (AMD). We address the strength of evidence between low-dose aspirin use and AMD and also discuss the risks and benefits of aspirin use in primary versus secondary prevention of cardiovascular diseases in these cases. We also highlight an ongoing randomized controlled trial in this area

UR - http://informahealthcare.com.ezproxy.lib.monash.edu.au/doi/pdf/10.1517/14740338.2014.914169

U2 - 10.1517/14740338.2014.914169

DO - 10.1517/14740338.2014.914169

M3 - Letter

VL - 13

SP - 691

EP - 693

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

SN - 1474-0338

IS - 6

ER -